Release
📈 Stocks
Xilio Therapeutics Appoints Dr. Houvras as New Chief Medical Officer
(18 hours ago)
Xilio Therapeutics strengthens its leadership team with the appointment of Dr. Houvras, a veteran in translational medicine and immuno-oncology, to oversee clinical…